Johnson & Johnson subsidiary escapes Canadian probe
Canada’s antitrust authority has dropped its abuse of dominance investigation into Janssen, as it could not prove the pharmaceutical company’s conduct hurt competition in the biosimilar drug market.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.